Boston Scientific Corp. (BSX)
57.90
+1.90
(+3.39%)
USD |
NYSE |
May 07, 09:44
Boston Scientific Cash from Investing (Quarterly) : -591.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -20.32B |
| Intuitive Surgical, Inc. | -914.50M |
| Stryker Corp. | -185.00M |
| Insulet Corp. | -- |
| Penumbra, Inc. | -225.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 348.00M |
| Cash from Financing (Quarterly) | -260.00M |
| Free Cash Flow | 3.475B |
| Free Cash Flow Per Share (Quarterly) | 0.1144 |
| Free Cash Flow to Equity (Quarterly) | 1.114B |
| Free Cash Flow to Firm (Quarterly) | 278.07M |
| Free Cash Flow Yield | 4.01% |